Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideCVSCVS Health
FinDog View：Bullish
JNJJohnson & Johnson
FinDog View：Bullish
| Metric | CVS | JNJ |
|---|
| Close | 90.25 | 273.20 |
| Market Cap | $116B | $666B |
| 1M | +5.32% | +3.20% |
| P/E (TTM) | 23.8 | 41.3 |
| Forward P/E | 10.4 | 22.0 |
| P/E 5-Yr Percentile | 65 | 100 |
| P/S | 0.3 | 6.7 |
| P/B | 1.5 | 7.8 |
| Dividend Yield | 3.49% | 3.12% |
| Latest Quarter Revenue | $106B | $25.4B |
| Revenue YoY | +7.3% | +5.9% |
| Gross Margin | 44.5% | 68.1% |
| Latest Quarter EPS | 2.31 | 0.09 |
| Avg Post-Earnings Move | ±2.3% | ±0.6% |
| EPS Beat Rate | — | 1 / 1 |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.94% | 1.18% |
| 90-Day Net Insider Buying | — | −$62.0M |
CVS · Revenue, Last 8 Quarters ($B)
JNJ · Revenue, Last 8 Quarters ($B)
